My NCBISign In
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
Alma Chavez-Blanco, Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Lucely Cetina, Myrna Candelaria, David Cantu, Aurora Gonzalez-Fierro, Patricia Garcia-Lopez, Pilar Zambrano, Carlos Perez-Plasencia, Gustavo Cabrera, Catalina Trejo-Becerril, Enrique Angeles, Alfonso Duenas-Gonzalez
Mol Cancer. 2005; 4: 22. Published online 2005 July 7. doi: 10.1186/1476-4598-4-22
PMCID:
PMC1198251
Abstract Full Text PDF–572K

Is Cited by the Following 16 Articles in this Archive:

A Full Suite of Histone and Histone Modifying Genes Are Transcribed in the Dinoflagellate Lingulodinium
Sougata Roy, David Morse
PLoS One. 2012; 7(4): e34340. Published online 2012 April 4. doi: 10.1371/journal.pone.0034340
PMCID:
PMC3319573
Abstract Full Text PDF–232K Supplementary Material
Interpreting clinical assays for histone deacetylase inhibitors
Nadine Martinet, Philippe Bertrand
Cancer Manag Res. 2011; 3: 117–141. Published online 2011 May 9. doi: 10.2147/CMR.S9661
PMCID:
PMC3101110
Abstract Full Text PDF–904K
PHASE 1 STUDY OF VALPROIC ACID IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID OR CNS TUMORS: A CHILDREN’S ONCOLOGY GROUP REPORT
Jack M. Su, Xiao-Nan Li, Patrick Thompson, Ching-Nan Ou, Ashish M. Ingle, Heidi Russell, Ching C. Lau, Peter C. Adamson, Susan M. Blaney
Clin Cancer Res. Author manuscript; available in PMC 2012 February 1.
Published in final edited form as: Clin Cancer Res. 2011 February 1; 17(3): 589–597. Published online 2010 November 29. doi: 10.1158/1078-0432.CCR-10-0738
PMCID:
PMC3064523
Abstract Full Text PDF–390K
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo, Delong Liu
J Hematol Oncol. 2010; 3: 5. Published online 2010 February 4. doi: 10.1186/1756-8722-3-5
PMCID:
PMC2827364
Abstract Full Text PDF–398K
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
Shundong Cang, Yuehua Ma, Delong Liu
J Hematol Oncol. 2009; 2: 22. Published online 2009 June 1. doi: 10.1186/1756-8722-2-22
PMCID:
PMC2695818
Abstract Full Text PDF–370K
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Florian R Fritzsche, Wilko Weichert, Annika Röske, Volker Gekeler, Thomas Beckers, Carsten Stephan, Klaus Jung, Katharina Scholman, Carsten Denkert, Manfred Dietel, Glen Kristiansen
BMC Cancer. 2008; 8: 381. Published online 2008 December 19. doi: 10.1186/1471-2407-8-381
PMCID:
PMC2631013
Abstract Full Text PDF–1.7M
Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?
Aleksander M Grabiec, Paul P Tak, Kris A Reedquist
Arthritis Res Ther. 2008; 10(5): 226. Published online 2008 October 17. doi: 10.1186/ar2489
PMCID:
PMC2592777
Abstract Full Text PDF–921K Supplementary Material
HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo
Blanca Segura-Pacheco, Berenice Avalos, Edgar Rangel, Dora Velazquez, Gustavo Cabrera
Genet Vaccines Ther. 2007; 5: 10. Published online 2007 September 24. doi: 10.1186/1479-0556-5-10
PMCID:
PMC2174455
Abstract Full Text PDF–520K Supplementary Material
The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study
Erick de la Cruz-Hernández, Enrique Pérez-Cárdenas, Adriana Contreras-Paredes, David Cantú, Alejandro Mohar, Marcela Lizano, Alfonso Dueñas-González
Virol J. 2007; 4: 18. Published online 2007 February 26. doi: 10.1186/1743-422X-4-18
PMCID:
PMC1819371
Abstract Full Text PDF–415K
Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid
María de Lourdes Mora-García, Alfonso Duenas-González, Jorge Hernández-Montes, Erick De la Cruz-Hernández, Enrique Pérez-Cárdenas, Benny Weiss-Steider, Edelmiro Santiago-Osorio, Vianney Francisco Ortíz-Navarrete, Víctor Hugo Rosales, David Cantú, Marcela Lizano-Soberón, Martha Patricia Rojo-Aguilar, Alberto Monroy-García
J Transl Med. 2006; 4: 55. Published online 2006 December 27. doi: 10.1186/1479-5876-4-55
PMCID:
PMC1781077
Abstract Full Text PDF–874K
A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer
Claudia Arce, Carlos Pérez-Plasencia, Aurora González-Fierro, Erick de la Cruz-Hernández, Alma Revilla-Vázquez, Alma Chávez-Blanco, Catalina Trejo-Becerril, Enrique Pérez-Cárdenas, Lucia Taja-Chayeb, Enrique Bargallo, Patricia Villarreal, Teresa Ramírez, Teresa Vela, Myrna Candelaria, Maria F. Camargo, Elizabeth Robles, Alfonso Dueñas-González
PLoS ONE. 2006; 1(1): e98. Published online 2006 December 20. doi: 10.1371/journal.pone.0000098
PMCID:
PMC1762324
Abstract Full Text PDF–221K Supplementary Material
Epigenetic aberrations and cancer
Miryam Ducasse, Mark A Brown
Mol Cancer. 2006; 5: 60. Published online 2006 November 8. doi: 10.1186/1476-4598-5-60
PMCID:
PMC1636665
Abstract Full Text PDF–421K
The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver
S Eyal, J G Lamb, M Smith-Yockman, B Yagen, E Fibach, Y Altschuler, H S White, M Bialer
Br J Pharmacol. 2006 October; 149(3): 250–260. Published online 2006 August 7. doi: 10.1038/sj.bjp.0706830
PMCID:
PMC2014277
Abstract Full Text PDF–244K
Hydralazine target: From blood vessels to the epigenome
Claudia Arce, Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Myrna Candelaria, Alfonso Dueñnas-Gonzalez
J Transl Med. 2006; 4: 10. Published online 2006 February 28. doi: 10.1186/1479-5876-4-10
PMCID:
PMC1413557
Abstract Full Text PDF–904K
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
Alma Chavez-Blanco, Carlos Perez-Plasencia, Enrique Perez-Cardenas, Claudia Carrasco-Legleu, Edgar Rangel-Lopez, Blanca Segura-Pacheco, Lucia Taja-Chayeb, Catalina Trejo-Becerril, Aurora Gonzalez-Fierro, Myrna Candelaria, Gustavo Cabrera, Alfonso Duenas-Gonzalez
Cancer Cell Int. 2006; 6: 2. Published online 2006 January 31. doi: 10.1186/1475-2867-6-2
PMCID:
PMC1408081
Abstract Full Text PDF–360K Supplementary Material
Epigenetics of cervical cancer. An overview and therapeutic perspectives
Alfonso Dueñas-González, Marcela Lizano, Myrna Candelaria, Lucely Cetina, Claudia Arce, Eduardo Cervera
Mol Cancer. 2005; 4: 38. Published online 2005 October 25. doi: 10.1186/1476-4598-4-38
PMCID:
PMC1291396
Abstract Full Text PDF–501K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk